ATLANTA--(BUSINESS WIRE)--Altea Therapeutics today announces the appointment of Dr. William R. Good to its Board of Directors.
“We are pleased to welcome such an experienced and successful scientist and thought leader in drug delivery to our Board,” said Dr. Eric Tomlinson, President and CEO of Altea Therapeutics. “I anticipate that Bill Good’s outstanding contributions to the commercial development of a number of successful drug delivery products, including transdermals, will aid greatly the continued development and expansion of our product portfolio.”
